Study objective is to evaluate the outcomes of placing gamma-irradiated corneal tissue (VisionGraft, CorneaGen, USA) within the cornea of patients with keratoconus, a procedure called Corneal Tissue Addition for Keratoconus (CTAK).
Using E gamma irradiated sterilized preserved corneal tissue, shaped corneal tissue inlays are placed in a keratoconic cornea. Preserved corneal tissue is currently available commercially from CorneaGen (VisionGraft,1200 6th Ave., STe.300, Seattle, WA 98101). Such tissue is currently used in a number of eye surgical procedures. It is considered suitable for corneal surgical procedures that do not require viable corneal endothelium, as is the case for a tissue enhancement procedure in keratoconus. The goal of the current protocol to evaluate the outcomes of placing gamma-irradiated preserved tissue within the keratoconic cornea in order to enhance corneal thickness, stability, and optical conformation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
A mid-stomal pocket will be made into the cornea with a femtosecond laser (Intralase). A small disc of gamma-irradiated preserved corneal tissue will then be placed into the pocket
Cornea and Laser Eye Institute, Hersh Vision Group
Teaneck, New Jersey, United States
Gamma-Irradiated Preserved Corneal Tissue Inlay
Change in mean keratometry on corneal topography
Time frame: 6 months
Gamma Irradiated Preserved Corneal Tissue Inlay
Inferior-Superior (I-S) ratio
Time frame: 6 months
Gamma Irradiated Preserved Corneal Tissue Inlay
Manifest refraction
Time frame: 6 months
Gamma Irradiated Preserved Corneal Tissue Inlay
Uncorrected distance visual acuity
Time frame: 6 months
Gamma Irradiated Preserved Corneal Tissue Inlay
Best spectacle corrected distance visual acuity
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.